Published in Telemedicine Law Weekly, January 13th, 2007
Study 1: A new study, "Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification," is now available. According to a study from Japan, "S: The aim of this study was to examine and clarify the preoperative markers that are useful for differentiating between benign and malignant lesions of intraductal papillary-mucinous neoplasms (IPMN) of the pancreas, grouped according to morphologic classification. There are various stages of pathology in IPMN, ranging from benign to malignant lesions. Although the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly